Psychedelics: AbbVie's Bold Investment in Mental Health

AbbVie's $1.2 billion investment marks a major shift in mental health treatment, embracing psychedelic-based therapies for depression. A potential game-changer in the pharmaceutical industry. #AbbVie #PsychedelicTherapy 🧠💊